newsfilter
← Latest News
GlobeNewswire·

Galecto to Participate in Oppenheimer's 33rd Annual Healthcare Conference

BOSTON, March 02, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company and a world leader in galectin biology focused on the development of novel treatments for fibrosis and